DelveInsight’s Epilepsy pipeline report depicts a robust space with 75+ active players working to develop 90+ pipeline therapies for Epilepsy treatment.

LivaNova (NASDAQ:LIVN) is one of the best mid cap pharma stocks to buy. Earlier in June, LivaNova announced the completion of its CORE-VNS study, which is a significant real-world evidence evaluation ...

Often, treatment is successful and people with epilepsy are able to stop taking medication after a few years. More than 70% of children with common types of epilepsy eventually go off medication.

However, with a deeper understanding of epilepsy and the different treatment options available today, patients and their support systems can feel more empowered and hopeful in managing their journeys.

Epilepsy is the most common chronic brain disease, with nearly 3 million adults in the U.S. diagnosed. Epilepsy can be disruptive, dangerous and terrifying. But, there is a way for those with ...

In the case of epilepsy, the diverse range of pathways and experiential differences that characterize unprovoked seizures remain unclear. So, finding the optimal treatment can take time.

NeuroOne’s innovative technology isn’t just limited to epilepsy treatment. The company plans to expand its applications to other areas, such as pain management for facial pain and lower back ...

In the United States, epilepsy impacts more than 200,000 individuals and does not reach rare disease status; however, Lennox-Gastaut syndrome, a rare childhood epilepsy, impacts 13.2 children per ...

NeuroPace is targeting the treatment of idiopathic generalized epilepsy (IGE), with plans to submit an FDA application in the second half of 2025. This expansion could open up a new market ...

Epilepsy is the most common chronic brain disease, with nearly 3 million adults in the U.S. diagnosed. Epilepsy can be disruptive, dangerous and terrifying. But, there is a way for those with ...

Epilepsy is the most common chronic brain disease, with nearly 3 million adults in the U.S. diagnosed. Epilepsy can be disruptive, dangerous and terrifying. But, there is a way for those with ...

One Queen Creek-area family is finding hope in an innovative epilepsy treatment. Caring for a medically complex child is never easy, but Brittany Miller, mom to 14-year-old Brooke, wants others ...